PL3886579T5 - Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu - Google Patents

Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu

Info

Publication number
PL3886579T5
PL3886579T5 PL19889740.7T PL19889740T PL3886579T5 PL 3886579 T5 PL3886579 T5 PL 3886579T5 PL 19889740 T PL19889740 T PL 19889740T PL 3886579 T5 PL3886579 T5 PL 3886579T5
Authority
PL
Poland
Prior art keywords
peg
phospholipid molecules
vivo organ
organ treatment
treatment
Prior art date
Application number
PL19889740.7T
Other languages
English (en)
Other versions
PL3886579T3 (pl
Inventor
Bo Nilsson
Kristina NILSSON EKDAHL
Marianne JENSEN WAERN
Yuji Teramura
Alireza BIGLARNIA
Original Assignee
Icoat Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=70851858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3886579(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icoat Medical Ab filed Critical Icoat Medical Ab
Publication of PL3886579T3 publication Critical patent/PL3886579T3/pl
Publication of PL3886579T5 publication Critical patent/PL3886579T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PL19889740.7T 2018-11-30 2019-11-29 Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu PL3886579T5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1851492 2018-11-30
PCT/SE2019/051215 WO2020112018A1 (en) 2018-11-30 2019-11-29 Ex vivo organ treatment with peg-phospholipid molecules

Publications (2)

Publication Number Publication Date
PL3886579T3 PL3886579T3 (pl) 2023-08-28
PL3886579T5 true PL3886579T5 (pl) 2026-02-09

Family

ID=70851858

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19889740.7T PL3886579T5 (pl) 2018-11-30 2019-11-29 Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu

Country Status (12)

Country Link
US (1) US20220022447A1 (pl)
EP (1) EP3886579B2 (pl)
JP (1) JP7465567B2 (pl)
KR (1) KR102828292B1 (pl)
CN (1) CN113056193B (pl)
AU (1) AU2019390222B2 (pl)
CA (1) CA3120057C (pl)
ES (1) ES2949977T3 (pl)
IL (1) IL283265B2 (pl)
MX (1) MX2021005859A (pl)
PL (1) PL3886579T5 (pl)
WO (1) WO2020112018A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113056193B (zh) 2018-11-30 2022-12-20 爱科特医药公司 用peg磷脂分子的离体器官处理
KR20220127808A (ko) * 2020-01-15 2022-09-20 아이코트 메디컬 에이비 Peg-지질
CN114225115B (zh) * 2021-09-27 2023-03-17 南开大学 无损修饰的含有活细胞的血管替代物及制备方法
US20250366467A1 (en) * 2022-06-15 2025-12-04 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
US11704507B1 (en) 2022-10-31 2023-07-18 Kudo, Inc. Systems and methods for automatic speech translation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301921A1 (en) * 1997-08-20 1999-02-25 John Graham Goddard Compositions containing polyethylene glycol and uses thereof
WO2004093658A2 (en) 2003-04-23 2004-11-04 Human Biosystems Improved methods and solutions for storing donor organs
WO2006093314A1 (ja) 2005-03-04 2006-09-08 National University Corporation, Tokyo Medical And Dental University 臓器機能維持改善液
CN103442675B (zh) * 2011-03-23 2016-04-06 维沃琳医药有限公司 用于将获取的器官维持能存活且可运输的装置
US9399027B2 (en) * 2011-09-08 2016-07-26 Virginia Commonwealth University Organ protection solution and its method of use
US10433538B2 (en) * 2012-10-12 2019-10-08 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for organ preservation
CN103626993B (zh) * 2013-11-05 2016-01-20 南京理工大学 聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物及其制备
CN113056193B (zh) 2018-11-30 2022-12-20 爱科特医药公司 用peg磷脂分子的离体器官处理

Also Published As

Publication number Publication date
US20220022447A1 (en) 2022-01-27
IL283265A (en) 2021-07-29
CA3120057C (en) 2025-05-27
AU2019390222B2 (en) 2023-12-14
JP7465567B2 (ja) 2024-04-11
EP3886579A4 (en) 2022-09-07
EP3886579A1 (en) 2021-10-06
PL3886579T3 (pl) 2023-08-28
MX2021005859A (es) 2021-07-16
KR20210097114A (ko) 2021-08-06
IL283265B2 (en) 2024-08-01
EP3886579C0 (en) 2023-06-07
CN113056193A (zh) 2021-06-29
WO2020112018A1 (en) 2020-06-04
BR112021009984A2 (pt) 2021-08-17
ES2949977T3 (es) 2023-10-04
CA3120057A1 (en) 2020-06-04
KR102828292B1 (ko) 2025-07-03
CN113056193B (zh) 2022-12-20
AU2019390222A1 (en) 2021-05-27
JP2022511767A (ja) 2022-02-01
EP3886579B1 (en) 2023-06-07
IL283265B1 (en) 2024-04-01
EP3886579B2 (en) 2025-12-24

Similar Documents

Publication Publication Date Title
PL3886579T5 (pl) Leczenie narządu ex vivo cząsteczkami peg-fosfolipidu
IL273550A (en) Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3
SMT202300418T1 (it) Trattamento di tumori positivi per lag-3
IL266690A (en) Agents targeting selected organs and tissues
GB201903546D0 (en) Cancer treatment
IL268463A (en) Cancer treatment
IL280677A (en) Tissue treatment with a substance that causes sensitivity and light and/or sound
ZA202100482B (en) Aromatic molecules for use in the treatment of pathological conditions
IL279277A (en) In vivo controlled combination therapy for treatment of cancer
IL287652A (en) Cancer treatment
IL285466A (en) Cancer treatment
ZA202100421B (en) Aromatic molecules for use in the treatment of pathological conditions
IL269121A (en) Usl-311 for use in the treatment of cancer
EP3706752A4 (en) COMBINATORY THERAPY FOR ANTI-CANCER TREATMENT
IL288905A (en) diagnosis and treatment
IL288035A (en) Cancer treatment
ZA202001435B (en) Abx196 for use in the treatment of bladder cancer
GB201906975D0 (en) Treatment of ards
GB201908076D0 (en) Skin treatment composition
GB201819920D0 (en) Cancer treatment
HK40032616A (en) Diagnostic and treatment kit
GB201910644D0 (en) Cancer Treatment
GB201907149D0 (en) Cancer treatment
GB201801195D0 (en) Skin repair treatment
GB201811431D0 (en) Cancer treatment